feed,title,long_url,short_url
BioRxiv,An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in vitro antiviral activity,https://biorxiv.org/cgi/content/short/2020.12.19.423537v1?rss=1,https://j.mp/3az6uC5
